Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc (NY: BHC )

7.395 -0.085 (-1.14%)
Streaming Delayed Price Updated: 10:05 AM EST, Dec 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,... 
Via Benzinga
'Well-Established' Eye Health Company Bausch + Lomb Gets Outperform Rating From This Analyst
Via Benzinga
Expert Ratings for Bausch Health Companies
Bausch Health Companies (NYSE:BHC) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Bausch Health To Appeal Expected Court Decision On Xifaxan Patents
Yesterday, Bausch Health Companies Inc (NYSE: BHC) stock closed 50% lower after the reports on the order on patent litigation over Xifaxan (rifaximin). 
Via Benzinga
Nasdaq Rises 100 Points; US Economy Shrinks Again In Q2
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Thursday. 
Via Benzinga
Why Bausch Health's Market Cap Is Being Cut In Half Thursday: 'A Near Worst-Case Scenario'
Shares of global health company Bausch Health Companies Inc (NYSE: BHC) are plunging Thursday after a Delaware federal judge issued an oral order on patents related to the company's Xifaxan drug. 
Via Benzinga
Bausch Health (BHC) Stock Plunges 50% on Patent News
With Bausch Health losing a critical patent battle enabling its key drug to suffer generic competition, BHC stock veritably crumbled. 
Via InvestorPlace
Meta, Charter Communications, Southwest Airlines And Some Other Big Stocks Moving Lower On Thursday
Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan. 
Via Benzinga
Bausch Health Crashes On Unexpected Loss As Bausch & Lomb Starts Trading
The new Bausch & Lomb started trading Tuesday as its former parent company crashed. 
Via Investor's Business Daily
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 108 companies set new 52-week lows. 
Via Benzinga
Bausch Health Companies: Q1 Earnings Insights
Bausch Health Companies (NYSE:BHC) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Nasdaq Dips Over 100 Points; Meta Earnings Miss Estimates
U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Thursday. 
Via Benzinga
NIO Stock Falls as Grizzly Research Targets the EV Maker in New Short Report
Shares of NIO stock are sinking lower today following the release of a Grizzly Research short report. Here's what you should know. 
Via InvestorPlace
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation... 
Via Benzinga
Opening Day: Golden Sun Rises In Debut As Ivanhoe Electric Delays IPO
Chinese tutorial services provider Golden Sun Education opened for trading this week, with its shares surging almost 300% following a $17.6 million initial public offering. Meanwhile, Ivanhoe Electric... 
Via Talk Markets
Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session
Gainers USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider. 
Via Benzinga
Bausch Health to Postpone Its Planned Initial Public Offering (Ipo) of Its Solta Medical Skin-care Division Due to Market Instability.
The IPO process for Solta drew "substantial investor interest," according to a statement released by Bausch Health. "However, the business 
Via Best Stocks
Topics Initial Public Offering
Exposures Securities Market
Cramer Gives His Opinion On Equinix, Bausch Health And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Bausch Health Companies Inc. 
Via Benzinga
Bausch Health Companies Earnings Perspective: Return On Capital Employed
Benzinga Pro data, Bausch Health Companies (NYSE:BHC) reported Q1 sales of $1.92 billion. Earnings fell to a loss of $66.00 million, resulting in a 191.67% decrease from last quarter. 
Via Benzinga
Looking Into Bausch Health Companies's Return On Capital Employed
Bausch Health Companies (NYSE:BHC) brought in sales totaling $1.92 billion during Q1 according to data provided by Benzinga Pro. However, earnings decreased 191.67%, resulting in a loss of $66.00... 
Via Benzinga
3 Value Stocks That Could 2x in a Recession
It might be tempting to say that valuation metrics are no longer useful for certain kinds of value stocks, but you need to adjust your focus. 
Via InvestorPlace
Billionaire Carl Icahn Is Betting Big on These 5 Stocks. Here’s Why.
Famed corporate raider Carl Icahn still manages a billion dollar portfolio for his family office. Here's what he's betting on. 
Via InvestorPlace
Jim Cramer Shares His Opinion On Roblox, Century Aluminum And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he can’t recommend Roblox Corp (NASDAQ: RBLX) as it is not making money. 
Via Benzinga
NYSE:BHC Investor Notice: Investigation over Possible Securities Laws Violations by Bausch Health Companies Inc.
San Diego, CA -- (SBWIRE) -- 05/18/2022 -- Bausch Health Companies Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
Bausch Health's Q1 Sales, Profits Fall On Supply Chain Challenges, Cuts FY22 Outlook
Bausch Health Companies Inc (NYSE: BHC) has reported Q1 revenues of $1.92 billion, down 5% Y/Y. Excluding the unfavorable impact of foreign exchange of $41 million and... 
Via Benzinga
Why Is GoodRx (GDRX) Stock Down Today?
GoodRx (GDRX) stock is slipping on Tuesday despite the healthcare company beating out estimates for the first quarter of 2022. 
Via InvestorPlace
Bausch Health (BHC) Stock Plunges 25% After Bausch + Lomb IPO
Bausch Health (BHC) stock is falling on Tuesday following the release of its earnings report for the first quarter of 2022. 
Via InvestorPlace
103 Biggest Movers From Yesterday
Gainers 
Via Benzinga
77 Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.